These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms. Addington J; Liu L; Perkins DO; Carrion RE; Keefe RS; Woods SW Schizophr Bull; 2017 Jan; 43(1):57-63. PubMed ID: 27798225 [TBL] [Abstract][Full Text] [Related]
25. Association between residential instability at individual and area levels and future psychosis in adolescents at clinical high risk from the North American Prodrome Longitudinal Study (NAPLS) consortium. Ku BS; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Compton MT; Cornblatt BA; Keshavan M; Mathalon DH; Perkins DO; Stone WS; Tsuang MT; Walker EF; Woods SW; Druss BG Schizophr Res; 2021 Dec; 238():137-144. PubMed ID: 34673386 [TBL] [Abstract][Full Text] [Related]
26. Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis. Shakeel MK; Lu L; Cannon TD; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Walker EF; Mathalon DH; Bearden CE; Addington J Schizophr Res; 2019 Feb; 204():334-336. PubMed ID: 30181061 [TBL] [Abstract][Full Text] [Related]
27. Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study. Walker EF; Trotman HD; Pearce BD; Addington J; Cadenhead KS; Cornblatt BA; Heinssen R; Mathalon DH; Perkins DO; Seidman LJ; Tsuang MT; Cannon TD; McGlashan TH; Woods SW Biol Psychiatry; 2013 Sep; 74(6):410-7. PubMed ID: 23562006 [TBL] [Abstract][Full Text] [Related]
28. Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosis. Santesteban-Echarri O; Liu L; Miller M; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Tsuang MT; Walker EF; Woods SW; Addington J Schizophr Res; 2022 Oct; 248():114-121. PubMed ID: 36030758 [TBL] [Abstract][Full Text] [Related]
29. Selection for psychosocial treatment for youth at clinical high risk for psychosis based on the North American Prodrome Longitudinal Study individualized risk calculator. Worthington MA; Miklowitz DJ; O'Brien M; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cannon TD Early Interv Psychiatry; 2021 Feb; 15(1):96-103. PubMed ID: 31943807 [TBL] [Abstract][Full Text] [Related]
30. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study. Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568 [TBL] [Abstract][Full Text] [Related]
31. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS). Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728 [TBL] [Abstract][Full Text] [Related]
32. Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort. Chung Y; Allswede D; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD; Neuroimage Clin; 2019; 23():101862. PubMed ID: 31150956 [TBL] [Abstract][Full Text] [Related]
33. External validation and extension of the NAPLS-2 and SIPS-RC personalized risk calculators in an independent clinical high-risk sample. Osborne KJ; Mittal VA Psychiatry Res; 2019 Sep; 279():9-14. PubMed ID: 31279247 [TBL] [Abstract][Full Text] [Related]
35. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis. Carrión RE; Auther AM; McLaughlin D; Olsen R; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cornblatt BA Schizophr Bull; 2019 Jun; 45(4):763-772. PubMed ID: 30351423 [TBL] [Abstract][Full Text] [Related]